Literature DB >> 6788699

Effect of monoclonal antibodies on phagocytosis and killing of Toxoplasma gondii by normal macrophages.

W E Hauser, J S Remington.   

Abstract

Treatment of intact toxoplasma tachyzoites with individual mouse monoclonal antibodies to toxoplasma which are directed against individual membrane-associated antigenic determinants facilitated the phagocytosis of toxoplasma and also prepared the toxoplasma for intracellular destruction by nonelicited mouse peritoneal macrophages. In instances in which the organisms survived intracellularly, their multiplication was significantly reduced. Such monoclonal antibodies should be useful in further elucidating the role of antibody in resistance to toxoplasma and other facultative and obligate intracellular organisms.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6788699      PMCID: PMC351494          DOI: 10.1128/iai.32.2.637-640.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  Respective role of antibodies and immune macrophages during acquired immunity against toxoplasmosis in mice.

Authors:  S Stadtsbaeder; B T Nguyen; M C Calvin-Preval
Journal:  Ann Immunol (Paris)       Date:  1975 Jun-Jul

2.  Macrophages and intracellular parasitism.

Authors:  T C Jones
Journal:  J Reticuloendothel Soc       Date:  1974-05

3.  Adoptive immunity to intracellular infection.

Authors:  J K Frenkel
Journal:  J Immunol       Date:  1967-06       Impact factor: 5.422

4.  A role for activated macrophages in resistance to infection with Toxoplasma.

Authors:  J S Remington; J L Krahenbuhl; J W Mendenhall
Journal:  Infect Immun       Date:  1972-11       Impact factor: 3.441

5.  The use of killed vaccines in immunization against an intracellular parasite: Toxoplasma gondii.

Authors:  J L Krahenbuhl; J Ruskin; J S Remington
Journal:  J Immunol       Date:  1972-02       Impact factor: 5.422

6.  Studies on the specificity of killing of intracellular pathogens by macrophages.

Authors:  R McLeod; J S Remington
Journal:  Cell Immunol       Date:  1977-11       Impact factor: 4.868

7.  Specific antibody-dependent killing of Toxoplasma gondii by normal macrophages.

Authors:  S E Anderson; S C Bautista; J S Remington
Journal:  Clin Exp Immunol       Date:  1976-12       Impact factor: 4.330

8.  Effect of antithymocyte serum on experimental toxoplasmosis in mice.

Authors:  O Strannegård; E Lycke
Journal:  Infect Immun       Date:  1972-05       Impact factor: 3.441

9.  Effect of normal and activated human macrophages on Toxoplasma gondii.

Authors:  S E Anderson; J S Remington
Journal:  J Exp Med       Date:  1974-05-01       Impact factor: 14.307

10.  Assessment in vitro of immunity against Toxoplasma gondii.

Authors:  T C Jones; L Len; J G Hirsch
Journal:  J Exp Med       Date:  1975-02-01       Impact factor: 14.307

View more
  8 in total

1.  Survival of immunoglobulin G-opsonized Toxoplasma gondii in nonadherent human monocytes.

Authors:  C E Fadul; J Y Channon; L H Kasper
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

2.  Toxoplasma gondii: ultrastructural localization of specific antigens and inhibition of intracellular multiplication by monoclonal antibodies.

Authors:  B Y Lee; M H Ahn; H C Kim; D Y Min
Journal:  Korean J Parasitol       Date:  2001-03       Impact factor: 1.341

3.  Prevention of peroral and congenital acquisition of Toxoplasma gondii by antibody and activated macrophages.

Authors:  P Eisenhauer; D G Mack; R McLeod
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

Review 4.  Monoclonal antibodies against microorganisms.

Authors:  R A Polin
Journal:  Eur J Clin Microbiol       Date:  1984-10       Impact factor: 3.267

5.  Antigen specific lymphocyte transformation induced by secreted antigens from Toxoplasma gondii.

Authors:  H P Hughes; C A Connelly; J E Strangeways; L Hudson
Journal:  Clin Exp Immunol       Date:  1984-12       Impact factor: 4.330

6.  Neutralization of Chlamydia trachomatis infectivity with antibodies to the major outer membrane protein.

Authors:  H D Caldwell; L J Perry
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

7.  Effect of genetic modification of antibody responsiveness on resistance to Toxoplasma gondii infection.

Authors:  M Siqueira; L S Drumond; M Gennari; V C Ferreira; M H Reis; G Biozzi
Journal:  Infect Immun       Date:  1985-05       Impact factor: 3.441

8.  The extracellular matrix protein mindin as a novel adjuvant elicits stronger immune responses for rBAG1, rSRS4 and rSRS9 antigens of Toxoplasma gondii in BALB/c mice.

Authors:  Xiaojing Sun; Mei Mei; Xu Zhang; Fusong Han; Boyin Jia; Xiaoyan Wei; Zhiguang Chang; Huijun Lu; Jigang Yin; Qijun Chen; Ning Jiang
Journal:  BMC Infect Dis       Date:  2014-08-04       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.